The American College of Physicians criticized that the 2017 blood pressure (BP) guideline may fall short in weighing the potential benefits against potential harms, costs, and anticipated variation in individual patient preferences, especially for average- and lower-risk adults 60 and older. Other experts echoed some of the same concerns, arguing against a one-size-fits-all BP goal. It may be reasonable to consider more aggressive treatment goals in the highest-risk patients. For everyone else, it may be more reasonable to continue defining hypertension as a BP of 140/90 mm Hg or higher and to take an individualized approach, especially for those with poor vascular compliance (i.e., pulse pressures above 80 to 90 mm Hg), who typically have dizziness and poor mentation as their systolic BP approaches 140 mm Hg; for many people over 70 with isolated systolic hypertension. Source: http://annals.org/; http://www.nejm.org/

hyangiu

Recent Posts

The Science and Skepticism around Seed Oils

A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…

2 days ago

Bedtime Antihypertensive Comparable to Morning Use

A Canadian study of adults with high blood pressure (BP) found no difference in health…

4 days ago

Obicetrapib Effective and Safe in Improving Lipids

Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…

1 week ago

Hyperlipidemias and Inflammation Independently and Synergistically Raise CVD Risk

A UK longitudinal associations study revealed that hyperlipidemias and inflammation independently and together raise the…

2 weeks ago

Ultraprocessed Food Consumption and Early Death

A study shows that eating a lot of highly processed foods is likely causing a…

3 weeks ago

Dose Response of Physical Activity in CVD and Mortality

Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…

3 weeks ago

This website uses cookies.